CIK 0001280776
- Non-accelerated filer
- Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562358443
- Phone
- +1 332-255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 100,000 shares at an average $5.48 ($548,335)
- 4 Open-market buy Director bought 150,000 shares at an average $4.89 ($733,140)
- 4 Open-market buy Director bought 59,200 shares at $4.19 ($247,870)
- 4 Open-market buy Director bought 130,000 shares at an average $4.01 ($521,229)
- 4 Open-market buy Director bought 10,000 shares at $4.00 ($39,969)
- 4 Open-market buy Director bought 50,000 shares at $3.53 ($176,615)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy General Counsel and Secretary bought 2,500 shares at an average $3.09 ($7,724)
- 4 Open-market buy Co-Chairman and CEO bought 10,000 shares at $3.10 ($30,981)
- 4 Open-market buy Director bought 16,000 shares at $3.00 ($48,069)
- 4 Open-market buy Director bought 20,000 shares at an average $3.07 ($61,319)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 16 · 313 filings